Cannabidiol activates neuronal Kv7 channels

Elife. 2022 Feb 18:11:e73246. doi: 10.7554/eLife.73246.

Abstract

Cannabidiol (CBD), a chemical found in the Cannabis sativa plant, is a clinically effective antiepileptic drug whose mechanism of action is unknown. Using a fluorescence-based thallium flux assay, we performed a large-scale screen and found enhancement of flux through heterologously expressed human Kv7.2/7.3 channels by CBD. Patch-clamp recordings showed that CBD acts at submicromolar concentrations to shift the voltage dependence of Kv7.2/7.3 channels in the hyperpolarizing direction, producing a dramatic enhancement of current at voltages near -50 mV. CBD enhanced native M-current in mouse superior cervical ganglion starting at concentrations of 30 nM and also enhanced M-current in rat hippocampal neurons. The potent enhancement of Kv2/7.3 channels by CBD may contribute to its effectiveness as an antiepileptic drug by reducing neuronal hyperexcitability.

Keywords: Dravet syndrome; Kv7.2; M-current; cannabinoids; epilepsy; hippocampus; mouse; neuroscience; rat.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • CHO Cells
  • Cannabidiol / pharmacology*
  • Cricetinae
  • Cricetulus
  • Electrophysiological Phenomena / drug effects
  • Gene Expression Regulation / drug effects
  • Humans
  • KCNQ2 Potassium Channel / genetics
  • KCNQ2 Potassium Channel / metabolism*
  • KCNQ3 Potassium Channel / genetics
  • KCNQ3 Potassium Channel / metabolism*
  • Neurons / drug effects
  • Neurons / metabolism*
  • Rats

Substances

  • KCNQ2 Potassium Channel
  • KCNQ3 Potassium Channel
  • Cannabidiol